Patient | | | WB MRI | | | | | PET CT | | | Reference standard | Location |
---|
| 0 | 1 | 2 | 3 | 4 | 0 | 1 | 2 | 3 | 4 | | |
1 | | | | | | | | | | | | |
2 | | | | | | | | | | | | |
3 | | | | | | | | | | | | |
4 | | 1 | | | | | 1 | | | | benign | liver |
4 | | | 1 | | | | | | | | benign | bone |
4 | | | | | | | 1 | | | | benign | lung |
5 | | | | 2 | | | 1 | | | | benign | lung |
6 | | | 1 | | | | | | 1 | | malignant | pleura |
6 | | | | 2 | | | | | | 2 | malignant | liver |
7 | | | | | | | | | | | | |
8 | | | | | | | | | | | | |
9 | | | | | | | | | | | | |
10 | | | | | | | | | | | | |
11 | | 1 | | | | | | | | | benign | brain |
11 | | | 1 | | | | | | 1 | | benign | adrenal |
12 | | | | 1 | | | | | | 2 | malignant | bone |
12 | | | | | 2 | | | | | | malignant | brain |
13 | | 1 | | | | | 1 | | | | benign | liver |
13 | | 1 | | | | | | | 1 | | malignant | liver |
13 | | | | | 1 | | | | | 1 | malignant | adrenal |
14 | | | | | | | | | | | | |
15 | | 1 | 1 | | | | 1 | | | | benign | bone |
15 | | | | 1 | | | | | | 1 | malignant | liver |
16 | | | | | 1 | | | | | 1 | malignant | bone |
16 | | | | | 4 | | | | | | malignant | brain |
17 | | | | | | | | | | | | |
18 | | | | | | | | | | | | |
19 | | | | | | | | | 1 | | benign | adrenal |
20 | | | | | | | | | | 1 | benign | lung |
21 | | | 1 | | | | | | | | benign | adrenal |
22 | | | | | 1 | | | | | 1 | malignant | bone |
23 | | | | | 2 | | | | | 2 | malignant | adrenal |
23 | | | | | 5 | | | | | | malignant | brain |
24 | | | 1 | | | | | | | | benign | liver |
25 | | | | | | | | | | | | |
26 | | 1 | | | | | 1 | | | | benign | bone |
27 | | 1 | | | | | 1 | | | | benign | bone |
28 | | | | | | | | | | | | |
- Abbreviations: WB-MRI, whole-body magnetic resonance imaging; PET/CT, positron emission tomography computed tomography
- Number of distant metastases of each grading score in 18F-FDG PET/CT and WB-MRI respectively. Grading of each lesion was performed for WB-MRI and 18F-FDG PET/CT respectively, and interpreted as 1: low suspicion; 2: moderate suspicion; 3: strong suspicion; and 4: definite tumor. Grading score 0: not depicted was not used in the setting of distant metastases evaluation. Lesions scoring 2 points or higher were considered malignant. The reference standard column shows the number of distant metastases according to at least 12 months follow-up data. In patients with distant lesions in more than one location, results are presented in several rows, one for each location. The brain is not included in 18F-FDG PET/CT